Mobile Health (Mhealth): Rethinking Innovation Management to Harmonize AI and Social Design

Global scale comparison of mHealth regulation
Chapter 1 Introduction of the concept of AI in the field of mHealth while discovering the trends in mHealth research field
1.1 Introduction1.2 Definition of AI handled in this Book1.3 Literature Review1.4 Methods1.4.1 Bibliometric Analysis1.4.2 Data collection1.4.3 Data Analysis1.5 Results1.5.1 Number of Publications in the mHealth Field1.5.2 Number of Publications in Countries and Regions1.5.3 Partnering Networks of countries and Regions1.5.4 Top Journals in the mHealth Field1.5.5 Top Keywords and Networks of mHealth Publications1.5.6 Chronological Trends of mHealth Publication in Countries and Regions1.6 Discussion1.7 Conclusion
Chapter 2 Relationship of Innovation and Regulation on mHealth
2.1 Introduction2.1.1 Background of Mobile Health Development2.1.2 Innovation in mHealth2.1.3 The Objective of This Research2.1.4 Theoretical Framework2.2 Methods2.2.1 Research on Regulations2.3 Results2.3.1 Regulatory Transition in USA2.4 Discussion2.4.1 Interactive Regulator2.4.2 Medical Entrepreneur2.4.3 Current Challenges and Future Perspective2.5 Limitations2.6 Conclusion
Chapter 3 The Current Situation of Mobile Health in China from the Perspective of Policy, Application, and User Acceptance: A Multi-Method Systematic Analysis
3.1 Introduction3.1.1 The Burden of Disease and the Current State of Healthcare in China3.1.2 Healthcare Reform in China3.1.3 Mobile Health3.1.4 Objective3.2 Method3.2.1 Data Collection3.2.2 Data analysis3.3 Results3.3.1 Summary Analysis of China’s mHealth Policies3.3.2 Current Status of Mobile Health Applications in China3.3.3 The User Acceptance of Mobile Health in China3.4.2 Factors that Affect the Use of Mobile Health Technology3.4.3 Policy Recommendations3.5 Limitations
Chapter 4 Digital Healthcare Development and mHealth in South Korea 4.1 Introduction4.2 Healthcare Industry with Aging Population Surrounding South Korea4.3 Healthcare-retaled Policies in the US and EU4.3.1 US Policy4.3.2 EU Policy4.4 Digital Healthcare Policy and Development in South Korea4.4.1 EMR as the Foundation of Healthcare - Introduction of EMR in South Korea4.4.2 Healthcare-related Policies in South Korea4.5 mHealth in South Korea4.6 Status of mHealth Business in South Korea4.6.1 mHealth through Public Private Partnership (PPP)4.7 Mobile Healthcare Service Provided by Public Health Centers4.7.1 Mobile Healthcare Service Provided by Public Healthcare Centres for High-Risk PeopleDiscussion of mHealth development with case studies4.7.2 Mobile Healthcare Service Provided by Public Health Centers for Senior4.7.3 Mobile Healthcare Service Provided by Public Health Centers for Youth4.8 COVID-19 and mHealth in South Korea4.8.1 Immigration Management4.8.2 Self-quarantine Monitoring Application4.8.3 Management of COVID-19 Positive Individuals4.9 South Korea mHealth Model Driving by Government4.10 Conclusion
Chapter 5 Regulations and the Status of Social Implementation of Services on mHealth in Japan
5.1 Introduction5.2 Types of Exis

Dr. Kodama joined Suntory Holdings Limited after graduating (1998) and completed master’s degree (2000) at Kyushu University Department of Pharmaceutical Sciences. He obtained a Ph.D. (Pharmaceutical Sciences) from Kyushu University in 2004. After predoctoral at RIKEN and postdoctoral training at several university, he contributed the industry-academic joint research at Hokkaido University as an associate professor and project manager (2010-2016). He has been appointed for an associate professor, Graduate School of Technology Management (MOT), Ritsumeikan University, since 2016 to present. He has been engaged in a variety of academic, business and projects management, especially in the field of life sciences. His areas of specialization are technology management, entrepreneurship, business development and bioinformatics. Recently, he is selected as Fellow of Fondation France-Japon de l’EHESS.

Prof. Dr. Shintaro Sengoku is Professor and Principal Investigator of School of Environment and Society, Tokyo Institute of Technology and Visiting Professor of the Institute for Future Initiatives, the University of Tokyo. He has professional experience in advisory services at McKinsey&Company and Fast Track Initiative, Inc., a venture capital focusing on the bio/health technology industry; research and education experience in the field of management of technology and innovation research at Graduate School of Pharmaceutical Sciences, the University of Tokyo, International Collaborative Center, Kyoto University and Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University.